Seema A. Bhat

Seema A. Bhat's research focuses on blood cancers, particularly chronic lymphocytic leukemia (CLL) and lymphoma, with emphasis on drug treatments such as Bruton's tyrosine kinase inhibitors (a class of drugs that block a specific enzyme involved in cancer cell growth) and combination chemoimmunotherapy regimens. Work includes clinical trials evaluating treatment safety, effectiveness, and disease management strategies, mostly published in hematology and oncology journals. Some publications also touch on other clinical trial methodologies unrelated to blood cancer, such as psychiatric drug trials.

Publication output has grown substantially over the last decade, rising from a handful of papers around 2017 to a sustained higher output averaging 24 papers per year over the most recent five years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026